Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
08 Jul 2024 Other relevant information The Company informs about the dividends payment.   Download
04 Jul 2024 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2024 Download
24 Jun 2024 Announcement of General Shareholders' Meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download
11 Jun 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 7 June 2024 and 11 June 2024 and end of the share buyback program Download
07 Jun 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 31 May and 6 June 2024 Download

Pages

Date Title Description PDF
16 Feb 2017 Información sobre resultados (2) ROVI releases the press release related to the full year 2016 results Download
16 Feb 2017 Información sobre resultados ROVI releases the presentation related to the full year 2016 results Download
16 Feb 2017 Informe Anual de Gobierno Corporativo ROVI releases the 2016 Annual Corporate Governance Report Download
10 Jan 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the fourth quarter of 2016 Download
22 Nov 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Neparvis in Spain Download

Pages